Angiogenesis Inhibitors: all 4,430 studies that test it
Page 33 of 45. Open to participants first (542), then studies with results posted, then the rest; newest registration first within each.
- Lenalidomide in Relapsed or Refractory Primary-cutaneous Large B-cell Lymphoma Leg-type : Multicentre Prospective Phase II Single Arm Trial of the French Study Group of Cutaneous LymphomaCompletedNCT01556035Phase 2
- Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple MyelomaTerminatedNCT01555281Phase 1/2
- Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid LeukemiaCompletedNCT01555268Phase 1
- Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma PatientsStatus unknownNCT01554852Phase 3
- Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer PatientsCompletedNCT01554059Phase 2
- Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL)CompletedNCT01553786Phase 2
- Lenalidomide and Dexamethasone in Primary Plasma Cell LeukemiaCompletedNCT01553357Phase 2
- Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal CancerStatus unknownNCT01551641Phase 2
- A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal MelanomaCompletedNCT01551459Phase 2
- Endostar Continued Pumping Into Vein Combining With Gemcitabine-Carboplatin to Treat Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT01549093Phase 2
- Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryCompletedNCT01548482Phase 1
- To Assess the Interaction Between Sunitinib and Ketoconazole to Reduce the Dose and Cost of SunitinibCompletedNCT01548170Phase 1
- Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic CancerCompletedNCT01547260Phase 1/2
- Lenalidomide as Second-line Treatment for Advanced Hepatocellular CarcinomaCompletedNCT01545804Phase 2
- Lenalidomide Plus Rituximab for Recurrent/Refractory CNS and Intraocular LymphomaCompletedNCT01542918Phase 1
- Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple MyelomaStatus unknownNCT01541332Phase 1/2
- Perioperative Treatment of Resectable Liver MetastasesWithdrawnNCT01540435Phase 2
- Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System TumorsCompletedNCT01538095Phase 1
- Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 YearsStatus unknownNCT01532856Phase 3
- A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer PatientsCompletedNCT01531790Phase 1
- Study of Bevacizumab in Combination with Alternating XELIRI and XELOX in Metastatic Colorectal CancerActive, not recruitingNCT01531595Phase 2
- Lenalidomide and Low Dose Dexamethasone Versus Bortezomib, Lenalidomide and Low Dose Dexamethasone for Induction, in Patients With Previously Untreated Multiple MyelomaCompletedNCT01530594Phase 3
- Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal CancerStatus unknownNCT01529164Phase 2
- Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung CancerStatus unknownNCT01527864Phase 2
- Risk-adapted Therapy for Primary Systemic (AL) AmyloidosisCompletedNCT01527032Phase 2
- Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First RecurrenceTerminatedNCT01526837Phase 1
- Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MMCompletedNCT01526694Phase 2
- Study to Determine the Maximum Tolerated Dose, Safety and Effectiveness of Pomalidomide for Patients With Sickle Cell DiseaseCompletedNCT01522547Phase 1
- Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular DegenerationStatus unknownNCT01521819Not applicable
- Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple MyelomaTerminatedNCT01518465Phase 2
- Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid TumorsCompletedNCT01514123Phase 1
- Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema)CompletedNCT01512966Phase 3
- Pomalidomide and Dexamethasone (PDex) in AL AmyloidosisCompletedNCT01510613Phase 2
- Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver MetastasesTerminatedNCT01508000Phase 2
- The ELLIPSE Study: A Phase-1 Study Evaluating the Tolerance of Bevacizumab Nasal Spray to Treat Epistaxis in Hereditary Hemorrhagic TelangiectasiaCompletedNCT01507480Phase 1
- ZGN-440 (Beloranib for Subcutaneous Injection) for Treatment of ObesityCompletedNCT01507077Phase 1
- Effect of the Adjunctive IVB Before PRPCompletedNCT01504724Phase 4
- Efficacy and Safety Study of Avastin to Treat Neovascularisation of the CorneaCompletedNCT01501760Phase 3
- FUSION Regimen: Combined Pro re Nata and Fixed Regimen Ranibizumab in Exudative Age-related Macular DegenerationCompletedNCT01500915Phase 4
- Study of Efficacy and Safety of Sunitinib Given on an Individualized ScheduleCompletedNCT01499121Phase 2
- Safety Study of Preoperative Sunitinib and Radiation in Soft Tissue SarcomaCompletedNCT01498835Phase 1
- Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib and Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple MyelomaCompletedNCT01497093Phase 1
- A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung CancerCompletedNCT01496742Phase 2
- Open Label to Study to Evaluate Effect of Alfilbercept on Patients With (FVPED) Fibrovascular Pigment Epithelial DetachmentWithdrawnNCT01495208Phase 4
- Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung CancerCompletedNCT01493843Phase 2
- TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian CancerTerminatedNCT01493505Phase 3
- Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular EdemaStatus unknownNCT01487629Phase 2
- Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic TelangiectasiaCompletedNCT01485224Phase 2
- ACVDL Treatment for Patients With Newly Diagnosed Multiple MyelomaCompletedNCT01481194Phase 2
- Trial of Neoadjuvant Endostar, Docetaxel and Epirubicin for Patients With Breast CancerStatus unknownNCT01479036Phase 3
- A Multiple-ascending-dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Pomalidomide (CC-4047) in Healthy Male SubjectsCompletedNCT01474330Phase 1
- Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular DegenerationCompletedNCT01473251Not applicable
- Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF TherapyCompletedNCT01472510Phase 2
- Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric CancerCompletedNCT01471470Phase 2
- A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple MyelomaTerminatedNCT01464034Phase 1/2
- Sequential Trial on Reduced Intensity Conditioning (RIC) Allogeneic TransplantationCompletedNCT01460420Phase 1/2
- Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNCT01459380Phase 1
- Pilot Study to Establish Safety & Efficacy of a Combination of Dexamethasone and Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukaemia (CLL)CompletedNCT01459211Phase 2
- Wet AMD Recurrence Rate in Patients Stable on Three Month Ranibizumab DosingCompletedNCT01453920Phase 4
- Randomized Trial Comparing Lenalidomide With Low Dose Dexamethasone Versus Lenalidomide in Second Line Multiple MyelomaCompletedNCT01450215Phase 2
- Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein OcclusionCompletedNCT01448018Phase 4
- Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)Active, not recruitingNCT01446133Phase 2
- PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)CompletedNCT01445899Phase 2
- Dasatinib in Combination With Bevacizumab to Treat Advanced Solid TumorsCompletedNCT01445509Phase 1
- Avastin Plus Radiotherapy in Elderly Patients With GlioblastomaCompletedNCT01443676Phase 2
- Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With BevacizumabCompletedNCT01442649Phase 2
- A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.WithdrawnNCT01441388Phase 1
- Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) PatientsCompletedNCT01440582Phase 1
- Acute Changes in Intraocular Cytokines After Intravitreal BevacizumabStatus unknownNCT01439178Not applicable
- Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma MultiformeCompletedNCT01435395Phase 1
- Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic SyndromeCompletedNCT01433965Phase 1
- Trial of Endostar Combined With CHOPT for T Cell LymphomaStatus unknownNCT01430013Phase 2
- Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Refractory or Relapsed Indolent Non-Hodgkin LymphomaCompletedNCT01429025Phase 1
- Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein OcclusionCompletedNCT01428388Not applicable
- DCE-MRI PET Bevacizumab Study in Rectal CancerWithdrawnNCT01426074Phase 2
- Effect of Intravitreal Bevacizumab on Focal Edema With Hard Exudates Secondary to Diabetic RetinopathyStatus unknownNCT01422018Not applicable
- Lenalidomide After Reduced-intensity Allogeneic Stem Cell Transplantation for Relapsed Multiple MyelomaTerminatedNCT01421927Phase 1
- 1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal CancerCompletedNCT01417494Phase 2
- A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin LymphomaStatus unknownNCT01412307Phase 1/2
- Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain MetastasesStatus unknownNCT01410370Phase 2
- Therapeutic Study of Bevacizumab Injection Directly Inside the Keloid TissueTerminatedNCT01408953Phase 2
- Study To Evaluate The Safety And Efficacy Of Lenalidomide For Refractory Cutaneous LupusCompletedNCT01408199Phase 4
- Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)WithdrawnNCT01406639Phase 1
- Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer PatientsCompletedNCT01402089Phase 4
- Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLLCompletedNCT01400685Phase 1
- A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare TumoursActive, not recruitingNCT01396408Phase 2
- Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular LymphomaCompletedNCT01393756Phase 2
- Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic AstrocytomaSuspendedNCT01386710Phase 1/2
- Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal CancerCompletedNCT01383343Phase 1
- Intralesional Bevacizumab Injection on Primary PterygiumStatus unknownNCT01380678Phase 3
- Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate CancerCompletedNCT01378091Phase 1
- Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein OcclusionCompletedNCT01377597Phase 3
- Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female VolunteersCompletedNCT01372761Phase 1
- First International Randomized Study in Malignant Progressive Pheochromocytoma and ParagangliomaCompletedNCT01371201Phase 2
- Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular GlaucomaCompletedNCT01370135Not applicable
- Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC)CompletedNCT01368848Phase 2
- Lenalidomide in Patients With Chronic Myelomonocytic LeukemiaStatus unknownNCT01368757Phase 1/2
- Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer PatientsStatus unknownNCT01368419Phase 2
- A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast CancerCompletedNCT01367028Phase 2
- A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous ChemotherapyCompletedNCT01364012Phase 3